(55) demonstrated the combined effect of the CXCL10 ligand and PD-1 antibody in a mouse colon cancer model by inserting the CXCL10 ligand into the oncolytic adenovirus binding them to the PD-1 antibody. Here, CXCL10 is linked to malignant colon neoplasm.